In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price target of $179.00. The company's shares closed last Thursday at $171.31. According to TipRanks.com, Biasio is a 4-star analyst with an average return of 6.7% and a 58.9% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Coherus Biosciences, and Intuitive Surgical. Johnson & Johnson has an analyst consensus of Moderate Buy, with a price target consensus of $189.17, which is an 11.2% upside from current levels.
https://www.tipranks.com/news/blurbs/credit-suisse-maintains-a-hold-rating-on-johnson-johnson-jnj?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Set 2022 até Out 2022 Click aqui para mais gráficos Johnson and Johnson.
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Out 2021 até Out 2022 Click aqui para mais gráficos Johnson and Johnson.